FDFAX
Price
$100.34
Change
-$0.13 (-0.13%)
Updated
Sep 6 closing price
FIJCX
Price
$99.90
Change
-$0.13 (-0.13%)
Updated
Sep 6 closing price
Ad is loading...

FDFAX vs FIJCX

Header iconFDFAX vs FIJCX Comparison
Open Charts FDFAX vs FIJCXBanner chart's image
Fidelity Select Consumer Staples Port
Price$100.34
Change-$0.13 (-0.13%)
VolumeN/A
CapitalizationN/A
Fidelity Advisor Consumer Staples Z
Price$99.90
Change-$0.13 (-0.13%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FDFAX vs FIJCX Comparison Chart
Loading...
VS
FDFAX vs. FIJCX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDFAX is a StrongBuy and FIJCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FDFAX (1.4B) and FIJCX (1.4B) have equal amount of cash in the bank . FIJCX pays higher dividends than FDFAX: FIJCX (1.90) vs FDFAX (1.78). FDFAX was incepted earlier than FIJCX: FDFAX (39 years) vs FIJCX (6 years). FDFAX (46.00) and FIJCX (46.00) have comparable annual turnover. FDFAX (0) and FIJCX (0) have matching initial minimum investment requirements. FIJCX (7.85) and FDFAX (7.76) have marching annual gain over last year. FIJCX (28.03) and FDFAX (27.52) have equivalent 5 years return.
FDFAXFIJCXFDFAX / FIJCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence39 years6 years-
Gain YTD10.21410.29299%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRA500N/A-
Net Assets1.4B1.4B100%
Annual Yield % from dividends1.781.9094%
Returns for 1 year7.767.8599%
Returns for 3 years7.237.5696%
Returns for 5 years27.5228.0398%
Returns for 10 years15.52N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATUS2.140.10
+4.90%
Altice USA
TSEM41.320.28
+0.68%
Tower Semiconductor Ltd
CTVA55.11-0.39
-0.70%
Corteva
HMST15.00-0.44
-2.85%
HomeStreet
CMMB2.29-0.13
-5.37%
Chemomab Therapeutics Ltd